-
Several drug makers plan to lower prices of vaccines for GAVI purchaseSeveral pharmaceutical companies have pledged to lower the prices of vaccines against childhood illnesses ahead of the GAVI Alliance conference in London next week, the Guardian reports (Quinn, 6/6).2011/6/7
-
PQA honors Kaiser Permanente for outstanding performance in medication safetyKaiser Permanente Colorado is one of only three health plans in the nation to receive a top honor for excellence in medication safety. The award, issued by the Pharmacy Quality Alliance, recognizes Ka2011/6/3
-
FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorderMylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applic2011/6/3
-
Spanish Medicines Agency grants IMP License to Midatech's clinical grade nanoparticlesMidatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicine2011/6/2
-
EMA accepts Pfizer's filing of axitinib for regulatory review to treat advanced renal cell carcinomaPfizer Inc. announced today that the European Medicines Agency (EMA) has accepted Pfizer's filing for regulatory review of axitinib for patients with advanced renal cell carcinoma (RCC) after failure2011/6/2
-
China's SFDA grants production license to TPI anti-diabetic drug GliclazideTianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other2011/6/2
-
Four departments require to further crack down on releasing false drug information and selling drugs illegally over the InternetIn order to consolidate the rectification achievements, continuously intensify the crackdown on releasing false drug information and selling drugs illegally over the Internet, and maintain strict supe2011/6/1
-
FDA approves Actavis’ Donepezil Hydrochloride 5mg and 10mg tabletsActavis, an international generic pharmaceutical company, today announced that it has received approval from the US Food & Drug Administration to market Donepezil Hydrochloride Tablets a generic e2011/6/1
-
Cancer drug helps prevent hypertensive heart diseaseA promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found. The drug, a type of histone2011/5/31
-
Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrheaThe U.S. Food and Drug Administration today approved Dificid (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD). Clostridium difficile (C. difficile) is a b2011/5/30